SS INNOVATIONS INTERNATIONAL
SSIINASDAQTrading Snapshot
- Day Range
- $2.96 – $3.01
- 52-Week Range
- $2.75 – $10.00
- Volume
- $2.00B
- Avg Volume
- $2.10B
- Shares Outstanding
- 200.1M
- Next Earnings
- Dec 3, 2026
Fundamentals Snapshot
- Annual Revenue
- $42M
- Last Q Revenue
- $14M
- P/E Ratio
- -45.7
- P/S Ratio
- 11.4x
- EPS (TTM)
- $-0.06
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +9.2%
Why Investors Own SSII
- ✓High-growth profile — revenue up +45.0% YoY with expanding US Equity exposure.
- ✓Healthy economics — 60% gross margin and 22% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
SS INNOVATIONS INTERNATIONAL
SSII
StockOtter · stockotter.spaceAbout SS INNOVATIONS INTERNATIONAL
SS Innovations International, Inc., situated in Fort Lauderdale, Florida, focuses on the development of sophisticated robotic systems for surgical use. Their offerings encompass the SSI Mantra, a specialized surgical robot, and SSI Mudra, a suite of surgical instruments designed to facilitate various operations, including robotic cardiac surgery. The company also provides SSI Maya, a dedicated platform for robotic surgical interventions, along with OMNI 3D HD, which delivers a real-time, high-definition 3D perspective of the surgical field within the operating room.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Analyst Ratings
ⓘLatest News & Updates
SS Innovations Provides Update on Continuing Progress and Milestones
-- Advancing global expansion, pediatric robotic surgery and telesurgery -- -- Growing SSi Mantra installations, procedures and utilization -- FORT LAUDERDALE, Fla., Sept. 10, 2026 (GLOBE NEWSWIRE) -- via IBN -- SS Innov
SS Innovations Reports Second Quarter 2026 Financial Results
Record quarterly revenue driven by continuing strong growth in SSi Mantra unit sales Record quarterly revenue driven by continuing strong growth in SSi Mantra unit sales
SS Innovations To Showcase the SSi Mantra Surgical Robotic System at SRS 2026
Company's advanced surgical robotic system will be on display, spotlighted in multiple breakout sessions, and featured in a kidney telesurgery to be broadcast live at the premier industry event Company's advanced surgica
SS Innovations Appoints Sarah M. Romano as Chief Financial Officer
Veteran medtech finance executive brings extensive public company and capital markets experience to support the Company's next phase of global growth Veteran medtech finance executive brings extensive public company and
SS Innovations Subsidiary SSICRS Graduates Inaugural Cardiac Robotic Surgery Training Class
New course empowers healthcare professionals through expert instruction and hands-on learning New course empowers healthcare professionals through expert instruction and hands-on learning
IBN Initiates Coverage of SS Innovations International, Inc.
AUSTIN, Texas, July 07, 2026 (GLOBE NEWSWIRE) -- via IBN – SS Innovations International, Inc. (NASDAQ: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and ac